A Little Experience Goes a Long Way: Chlormethine/Mechlorethamine Treatment Duration as a Function of Clinician-Level Patient Volume for Mycosis Fungoides Cutaneous T-Cell Lymphoma (MF-CTCL)—A Retrospective Cohort Study

Topical chlormethine yields high response rates in mycosis fungoides cutaneous T-cell lymphoma with early discontinuation often attributed to skin reactions. We evaluated over 4,000 patients and found an association of clinician case volume with treatment duration and early discontinuation of chlorm...

Full description

Saved in:
Bibliographic Details
Published in:Frontiers in medicine 2021-07, Vol.8, p.679294-679294
Main Authors: Querfeld, Christiane, Pacheco, Theresa, Haverkos, Bradley, Binder, Gary, Angello, James, Poligone, Brian
Format: Article
Language:English
Subjects:
chlormethine gel
cutaneous T-cell lymphoma
dermatitis
mechlorethamine
Medicine
patient volume
treatment outcomes
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c439t-8f291334f8e32d3b9bc8e9159dd45696e6777153b4b29713480f9f1cefca97e33
cites cdi_FETCH-LOGICAL-c439t-8f291334f8e32d3b9bc8e9159dd45696e6777153b4b29713480f9f1cefca97e33
container_end_page 679294
container_issue
container_start_page 679294
container_title Frontiers in medicine
container_volume 8
creator Querfeld, Christiane
Pacheco, Theresa
Haverkos, Bradley
Binder, Gary
Angello, James
Poligone, Brian
description Topical chlormethine yields high response rates in mycosis fungoides cutaneous T-cell lymphoma with early discontinuation often attributed to skin reactions. We evaluated over 4,000 patients and found an association of clinician case volume with treatment duration and early discontinuation of chlormethine gel. The minority of clinicians with high patient volume markedly outperformed clinicians with only few patients on both outcome parameters, yet case volume as low as five patients seemed to mark a threshold for avoiding early discontinuation of treatment regimen.
doi_str_mv 10.3389/fmed.2021.679294
format article
fullrecord <record><control><sourceid>proquest_doaj_</sourceid><recordid>TN_cdi_doaj_primary_oai_doaj_org_article_9306cc4e59054abdb8153d8dde02a32c</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><doaj_id>oai_doaj_org_article_9306cc4e59054abdb8153d8dde02a32c</doaj_id><sourcerecordid>2553238667</sourcerecordid><originalsourceid>FETCH-LOGICAL-c439t-8f291334f8e32d3b9bc8e9159dd45696e6777153b4b29713480f9f1cefca97e33</originalsourceid><addsrcrecordid>eNpVks1u1DAUhSMEolXpnqWXZZGpY-fHZoFUhU6plBEIhp-d5dg3M66SeLCdEbPjIXg9NjwJTqdCdGUf-97vWscnSV5meEEp45fdAHpBMMkWZcUJz58kp4TwMmUF-_b0v_1Jcu79HcY4o6TIM_o8OaE5qaqyYKfJ7yvUmBB6QNc_duAMjArQjQWPJGrsuEFf5eE1qre9dQOErRnhcgVqllHJIWq0diDDAGNAbycng7EjknP7chrVvbIdqnszGmXkmDawhx59iHVzxxfbTwOgzjq0OijrjZ_bNtbo-IJ6CnIEO3m0Tmvoe9Qcht3WDhJdrJZpva6bV39-_rpCHyE463cQp-0B1XZrXUCfwqQPL5Jnnew9nD-sZ8nn5fW6fpc2729u66smVTnlIWUd4RmleceAEk1b3ioGPCu41nlR8hLKqqqygrZ5S3iV0ZzhjneZgk5JXgGlZ8ntkautvBM7ZwbpDsJKI-4PrNsI6YJRPQhOcalUDgXHRS5b3bII1kxrwERSoiLrzZG1m9r4wyra5GT_CPr4ZjRbsbF7wQiLL2MRcPEAcPb7BD6IwXgV_TuaKUhRUEJZWVaxFB9LVTTQO-j-jcmwmEMm5pCJOWTiGDL6FzloyRI</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2553238667</pqid></control><display><type>article</type><title>A Little Experience Goes a Long Way: Chlormethine/Mechlorethamine Treatment Duration as a Function of Clinician-Level Patient Volume for Mycosis Fungoides Cutaneous T-Cell Lymphoma (MF-CTCL)—A Retrospective Cohort Study</title><source>PubMed Central</source><creator>Querfeld, Christiane ; Pacheco, Theresa ; Haverkos, Bradley ; Binder, Gary ; Angello, James ; Poligone, Brian</creator><creatorcontrib>Querfeld, Christiane ; Pacheco, Theresa ; Haverkos, Bradley ; Binder, Gary ; Angello, James ; Poligone, Brian</creatorcontrib><description>Topical chlormethine yields high response rates in mycosis fungoides cutaneous T-cell lymphoma with early discontinuation often attributed to skin reactions. We evaluated over 4,000 patients and found an association of clinician case volume with treatment duration and early discontinuation of chlormethine gel. The minority of clinicians with high patient volume markedly outperformed clinicians with only few patients on both outcome parameters, yet case volume as low as five patients seemed to mark a threshold for avoiding early discontinuation of treatment regimen.</description><identifier>ISSN: 2296-858X</identifier><identifier>EISSN: 2296-858X</identifier><identifier>DOI: 10.3389/fmed.2021.679294</identifier><identifier>PMID: 34277658</identifier><language>eng</language><publisher>Frontiers Media S.A</publisher><subject>chlormethine gel ; cutaneous T-cell lymphoma ; dermatitis ; mechlorethamine ; Medicine ; patient volume ; treatment outcomes</subject><ispartof>Frontiers in medicine, 2021-07, Vol.8, p.679294-679294</ispartof><rights>Copyright © 2021 Querfeld, Pacheco, Haverkos, Binder, Angello and Poligone. 2021 Querfeld, Pacheco, Haverkos, Binder, Angello and Poligone</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c439t-8f291334f8e32d3b9bc8e9159dd45696e6777153b4b29713480f9f1cefca97e33</citedby><cites>FETCH-LOGICAL-c439t-8f291334f8e32d3b9bc8e9159dd45696e6777153b4b29713480f9f1cefca97e33</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC8283488/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC8283488/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,723,776,780,881,27903,27904,53769,53771</link.rule.ids></links><search><creatorcontrib>Querfeld, Christiane</creatorcontrib><creatorcontrib>Pacheco, Theresa</creatorcontrib><creatorcontrib>Haverkos, Bradley</creatorcontrib><creatorcontrib>Binder, Gary</creatorcontrib><creatorcontrib>Angello, James</creatorcontrib><creatorcontrib>Poligone, Brian</creatorcontrib><title>A Little Experience Goes a Long Way: Chlormethine/Mechlorethamine Treatment Duration as a Function of Clinician-Level Patient Volume for Mycosis Fungoides Cutaneous T-Cell Lymphoma (MF-CTCL)—A Retrospective Cohort Study</title><title>Frontiers in medicine</title><description>Topical chlormethine yields high response rates in mycosis fungoides cutaneous T-cell lymphoma with early discontinuation often attributed to skin reactions. We evaluated over 4,000 patients and found an association of clinician case volume with treatment duration and early discontinuation of chlormethine gel. The minority of clinicians with high patient volume markedly outperformed clinicians with only few patients on both outcome parameters, yet case volume as low as five patients seemed to mark a threshold for avoiding early discontinuation of treatment regimen.</description><subject>chlormethine gel</subject><subject>cutaneous T-cell lymphoma</subject><subject>dermatitis</subject><subject>mechlorethamine</subject><subject>Medicine</subject><subject>patient volume</subject><subject>treatment outcomes</subject><issn>2296-858X</issn><issn>2296-858X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2021</creationdate><recordtype>article</recordtype><sourceid>DOA</sourceid><recordid>eNpVks1u1DAUhSMEolXpnqWXZZGpY-fHZoFUhU6plBEIhp-d5dg3M66SeLCdEbPjIXg9NjwJTqdCdGUf-97vWscnSV5meEEp45fdAHpBMMkWZcUJz58kp4TwMmUF-_b0v_1Jcu79HcY4o6TIM_o8OaE5qaqyYKfJ7yvUmBB6QNc_duAMjArQjQWPJGrsuEFf5eE1qre9dQOErRnhcgVqllHJIWq0diDDAGNAbycng7EjknP7chrVvbIdqnszGmXkmDawhx59iHVzxxfbTwOgzjq0OijrjZ_bNtbo-IJ6CnIEO3m0Tmvoe9Qcht3WDhJdrJZpva6bV39-_rpCHyE463cQp-0B1XZrXUCfwqQPL5Jnnew9nD-sZ8nn5fW6fpc2729u66smVTnlIWUd4RmleceAEk1b3ioGPCu41nlR8hLKqqqygrZ5S3iV0ZzhjneZgk5JXgGlZ8ntkautvBM7ZwbpDsJKI-4PrNsI6YJRPQhOcalUDgXHRS5b3bII1kxrwERSoiLrzZG1m9r4wyra5GT_CPr4ZjRbsbF7wQiLL2MRcPEAcPb7BD6IwXgV_TuaKUhRUEJZWVaxFB9LVTTQO-j-jcmwmEMm5pCJOWTiGDL6FzloyRI</recordid><startdate>20210702</startdate><enddate>20210702</enddate><creator>Querfeld, Christiane</creator><creator>Pacheco, Theresa</creator><creator>Haverkos, Bradley</creator><creator>Binder, Gary</creator><creator>Angello, James</creator><creator>Poligone, Brian</creator><general>Frontiers Media S.A</general><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope><scope>DOA</scope></search><sort><creationdate>20210702</creationdate><title>A Little Experience Goes a Long Way: Chlormethine/Mechlorethamine Treatment Duration as a Function of Clinician-Level Patient Volume for Mycosis Fungoides Cutaneous T-Cell Lymphoma (MF-CTCL)—A Retrospective Cohort Study</title><author>Querfeld, Christiane ; Pacheco, Theresa ; Haverkos, Bradley ; Binder, Gary ; Angello, James ; Poligone, Brian</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c439t-8f291334f8e32d3b9bc8e9159dd45696e6777153b4b29713480f9f1cefca97e33</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2021</creationdate><topic>chlormethine gel</topic><topic>cutaneous T-cell lymphoma</topic><topic>dermatitis</topic><topic>mechlorethamine</topic><topic>Medicine</topic><topic>patient volume</topic><topic>treatment outcomes</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Querfeld, Christiane</creatorcontrib><creatorcontrib>Pacheco, Theresa</creatorcontrib><creatorcontrib>Haverkos, Bradley</creatorcontrib><creatorcontrib>Binder, Gary</creatorcontrib><creatorcontrib>Angello, James</creatorcontrib><creatorcontrib>Poligone, Brian</creatorcontrib><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><collection>Directory of Open Access Journals</collection><jtitle>Frontiers in medicine</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Querfeld, Christiane</au><au>Pacheco, Theresa</au><au>Haverkos, Bradley</au><au>Binder, Gary</au><au>Angello, James</au><au>Poligone, Brian</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>A Little Experience Goes a Long Way: Chlormethine/Mechlorethamine Treatment Duration as a Function of Clinician-Level Patient Volume for Mycosis Fungoides Cutaneous T-Cell Lymphoma (MF-CTCL)—A Retrospective Cohort Study</atitle><jtitle>Frontiers in medicine</jtitle><date>2021-07-02</date><risdate>2021</risdate><volume>8</volume><spage>679294</spage><epage>679294</epage><pages>679294-679294</pages><issn>2296-858X</issn><eissn>2296-858X</eissn><abstract>Topical chlormethine yields high response rates in mycosis fungoides cutaneous T-cell lymphoma with early discontinuation often attributed to skin reactions. We evaluated over 4,000 patients and found an association of clinician case volume with treatment duration and early discontinuation of chlormethine gel. The minority of clinicians with high patient volume markedly outperformed clinicians with only few patients on both outcome parameters, yet case volume as low as five patients seemed to mark a threshold for avoiding early discontinuation of treatment regimen.</abstract><pub>Frontiers Media S.A</pub><pmid>34277658</pmid><doi>10.3389/fmed.2021.679294</doi><tpages>1</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 2296-858X
ispartof Frontiers in medicine, 2021-07, Vol.8, p.679294-679294
issn 2296-858X
2296-858X
language eng
recordid cdi_doaj_primary_oai_doaj_org_article_9306cc4e59054abdb8153d8dde02a32c
source PubMed Central
subjects chlormethine gel
cutaneous T-cell lymphoma
dermatitis
mechlorethamine
Medicine
patient volume
treatment outcomes
title A Little Experience Goes a Long Way: Chlormethine/Mechlorethamine Treatment Duration as a Function of Clinician-Level Patient Volume for Mycosis Fungoides Cutaneous T-Cell Lymphoma (MF-CTCL)—A Retrospective Cohort Study
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-23T13%3A36%3A45IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_doaj_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=A%20Little%20Experience%20Goes%20a%20Long%20Way:%20Chlormethine/Mechlorethamine%20Treatment%20Duration%20as%20a%20Function%20of%20Clinician-Level%20Patient%20Volume%20for%20Mycosis%20Fungoides%20Cutaneous%20T-Cell%20Lymphoma%20(MF-CTCL)%E2%80%94A%20Retrospective%20Cohort%20Study&rft.jtitle=Frontiers%20in%20medicine&rft.au=Querfeld,%20Christiane&rft.date=2021-07-02&rft.volume=8&rft.spage=679294&rft.epage=679294&rft.pages=679294-679294&rft.issn=2296-858X&rft.eissn=2296-858X&rft_id=info:doi/10.3389/fmed.2021.679294&rft_dat=%3Cproquest_doaj_%3E2553238667%3C/proquest_doaj_%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c439t-8f291334f8e32d3b9bc8e9159dd45696e6777153b4b29713480f9f1cefca97e33%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2553238667&rft_id=info:pmid/34277658&rfr_iscdi=true